Natraceutical is to hold a stake of 39% in Naturex and become board members, alongside SGD, the family-controlled holding company of Jacques Dikansky, Naturex’s chairman and CEO, who will remain the reference shareholder in terms of voting rights.
The transaction also comprises €38m for Natraceutical, debt or cash, €10m of which will not be made effective until the confirmation of both companies’ year-end results.
Once the merge will be completed, Naturex will have production sites in Europe (France, Italy, Spain, Switzerland and the UK), the US, Morocco, Australia and Brazil and own sales offices in the US, Europe and Asia, thus being ideally placed to take advantage of the ongoing growth and consolidation of this sector.
Source: Natraceutical Group
© FoodBev Media Ltd 2020